Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02198092 · ClinicalTrials.gov registry record
Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 24
- Enrollment target
NCT02198092: Completed study, sponsored by University of Pennsylvania.
NCT02198092 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02198092 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
This is an observational, case-control study evaluating the quantitative level of Septin9 in plasma pre- and post-colectomy in hereditary colorectal cancer (CRC) syndrome patients (Familial Adenomatous Polyposis (FAP), Lynch syndrome (also known as HNPCC), and Multiple Adenomatous Polyposis (MAP, also known as MYK/MYH) cases) and genetically related FAP-family members as controls and references.
Primary Outcome
The primary objective of the study is the observational analysis of quantitative Septin9 plasma levels over time in hereditary CRC syndrome patients pre- and post-colectomy.
Interventions
- OTHER Epi proColon Testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2014-07 |
| Est. Completion | 2019-08 |
What the finished NCT02198092 record still lists
NCT02198092 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 24 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Epi proColon Testing is the first listed.
NCT02198092 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02198092 about?
NCT02198092 is a clinical study titled "Preliminary Evaluation of Septin9 in Patients With Hereditary Colon Cancer Syndromes". This is an observational, case-control study evaluating the quantitative level of Septin9 in plasma pre- and post-colectomy in hereditary colorectal cancer (CRC) syndrome patients (Familial Adenomatous Polyposis (FAP), Lynch syndrome (also known as HNPCC), and Multiple Adenomatous Polyposis (MAP, al...
What is the current status of trial NCT02198092?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2014-07. Estimated completion is 2019-08.
What interventions are being tested in trial NCT02198092?
The interventions under investigation include: Epi proColon Testing (OTHER).
Who is sponsoring clinical trial NCT02198092?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia